Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction

Gastric adenocarcinomas involving the esophagogastric junction represent a particular therapeutic problem because they lie in the border area between two body cavities: the thorax and the abdomen. The prognosis of gastric adenocarcinomas involving esophagogastric junction is poor because there is wi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of clinical oncology 1999-06, Vol.22 (3), p.253-257
Hauptverfasser:	RYOO, B.-Y, KANG, Y.-K, SHIM, Y. M, KIM, C.-M, ZO, J. I, IM, Y.-H, KIM, Y.-J, KIM, B.-S, KIM, T. Y, JUNG, S.-H, PARK, J. H, BAEK, H. J, KIM, Y.-C
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - pathology Adenocarcinoma - surgery Adult Aged Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Chemotherapy, Adjuvant Cisplatin - administration & dosage Combined treatments (chemotherapy of immunotherapy associated with an other treatment) Esophagogastric Junction Etoposide - administration & dosage Female Fluorouracil - administration & dosage Humans Male Medical sciences Middle Aged Neoplasm Staging Pharmacology. Drug treatments Pilot Projects Proportional Hazards Models Stomach Neoplasms - drug therapy Stomach Neoplasms - pathology Stomach Neoplasms - surgery Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!